COMPANY
Consegna Pharma
Timeline
- Grant Government grant — SBIR: $377,843 (annual award, as published), announced Aug 11, 2025. Agency: NIH/NIDA. Source: government award database. source ↗
Funding
- Government grant — SBIR: $377,843 (annual award, as published), announced Aug 11, 2025. Agency: NIH/NIDA. Source: government award database. source ↗
NIH awards 5
- NIH award 5R44DA050386-03 FY2024: $837,364 awarded for that fiscal year; activity R44 (SBIR); PI ZANA, LAWRENCE J; recipient as written: CONSEGNA PHARMA, INC., PITTSBURGH, PA. IND-enabling development of a long-durat source ↗
- NIH award 2R44DA050386-02 FY2023: $1,330,781 awarded for that fiscal year; activity R44 (SBIR); PI ZANA, LAWRENCE J; recipient as written: CONSEGNA PHARMA, INC., PITTSBURGH, PA. IND-enabling development of a long-dur source ↗
- NIH award 1R43DA059056-01 FY2023: $326,500 awarded for that fiscal year; activity R43 (SBIR); PI ZANA, LAWRENCE J; recipient as written: CONSEGNA PHARMA, INC., PITTSBURGH, PA. Long-acting injectable ketamine for impr source ↗
- NIH award 3R41DA050386-01S1 FY2020: $87,234 awarded for that fiscal year; activity R41 (STTR); PI AVERICK, SAADYAH; recipient as written: CONSEGNA PHARMA, INC., PITTSBURGH, PA. Prevention of renarcotization from synt source ↗
- NIH award 1R41DA050386-01 FY2019: $217,970 awarded for that fiscal year; activity R41 (STTR); PI AVERICK, SAADYAH; recipient as written: CONSEGNA PHARMA, INC., PITTSBURGH, PA. Prevention of renarcotization from synth source ↗